Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
מצבים רפואיים
Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult · Cervical Cancer · Colorectal Cancer · Esophageal Cancer · Esophageal Squamous Cell Carcinoma · Gastric Cancer · Gastroesophageal Junction Adenocarcinoma · Head and Neck Squamous Cell Carcinoma · Melanoma · Merkel Cell Carcinoma · Microsatellite Instability-High Solid Malignant Tumor · Mismatch Repair Deficient Solid Malignant Tumor · Microsatellite Instability-High Colorectal Cancer · Mismatch Repair Deficient Colorectal Cancer · Non-small Cell Lung Cancer · Renal Cell Carcinoma · Small Cell Lung Cancer · Squamous Cell Carcinoma · Urothelial Carcinoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Precision NextGen Oncology, Beverly Hills, California, United States
Contact: Principal Investigator (Kamlesh Sankhala, MD)OPN Healthcare, Inc, Glendale, California, United States
Contact: Principal Investigator (Vu Phan, MD)University of Southern California, Los Angeles, California, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Alexander Mohler, MD)Baylor, Scott and White Research Institute, Dallas, Texas, United States
Contact: Principal Investigator (Divya Mella, MD)Northwest Medical Specialties, Tacoma, Washington, United States
Contact: Principal Investigator (Jorge Chaves, MD)
מובילי המחקר
Tom Chen, MD, PhD
Study Chair
NeOnc Technologies
Josh Neman, PhD
Study Director
NeOnc Technologies Holdings, Inc.